MAM
WX

Myriad Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Myriad Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-418,728
Closed -$15.4M – 44
2014
Q1 		$15.4M Buy
+418,728
New +$15.4M 3.07% 12

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Myriad Asset Management's WX Position: Q2 2014 in Review

Myriad Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2014, closing a stake of 418,728 shares — an estimated $15.4M sold.

Myriad Asset Management first reported a position in WX in Q1 2014 and held it in 1 quarter. The position peaked at $15.4M in Q1 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2014.

  • Myriad Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2014 after selling out during the quarter.
  • Myriad Asset Management sold 418,728 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2014, an estimated $15.4M.
  • Myriad Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 1 quarter.
  • Myriad Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $15.4M in Q1 2014.
  • 154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2014.

Based on Myriad Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.